Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 181,236 shares traded hands during trading, an increase of 411% from the previous session’s volume of 35,453 shares.The stock last traded at $127.5350 and had previously closed at $126.48.
Invesco Pharmaceuticals ETF Stock Performance
The company has a market cap of $558.60 million, a PE ratio of 15.59 and a beta of 0.45. The company has a 50 day simple moving average of $124.81 and a two-hundred day simple moving average of $114.07.
Institutional Investors Weigh In On Invesco Pharmaceuticals ETF
Hedge funds have recently made changes to their positions in the stock. Fifth Third Bancorp acquired a new position in Invesco Pharmaceuticals ETF during the first quarter worth $36,000. Global Assets Advisory LLC bought a new position in Invesco Pharmaceuticals ETF in the 1st quarter valued at $42,000. IFP Advisors Inc lifted its stake in shares of Invesco Pharmaceuticals ETF by 31.3% during the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in Invesco Pharmaceuticals ETF in the second quarter worth about $55,000. Finally, Rockefeller Capital Management L.P. raised its holdings in Invesco Pharmaceuticals ETF by 20.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after purchasing an additional 209 shares during the last quarter.
About Invesco Pharmaceuticals ETF
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
See Also
- Five stocks we like better than Invesco Pharmaceuticals ETF
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
